This argues against a particular implication of this IL-17-producing CD8+ T cell subset in the pathophysiology of MS (92, 95), similar to what has been described for psoriasis, where conventional IL-17-producing CD8+ T cells might be more pathogenic than MAIT cells (87). The gene discussed is IL17A; the disease is myeloid sarcoma.